Related Experiment Video
Updated: Aug 5, 2026

07:02
Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Peroxidasin expression patterns predict fibrosis and kidney function decline in IgA nephropathy
Roberto Silva1,2, Isabel Brandão3,4, Tony J Chen5
1Department of Anatomic Pathology, São João Local Health Unit and University Hospital, Porto, Portugal.
Clinical and Experimental Nephrology
|July 27, 2026
Summary
Peroxidasin (PXDN) expression changes in IgA nephropathy (IgAN) kidney tissue, showing increased levels in fibrotic areas and correlating with kidney dysfunction. These findings suggest PXDN
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Peroxidasin (PXDN) is a heme peroxidase involved in basement membrane assembly.
- PXDN is implicated in fibrotic processes, but its role in kidney disease is not well understood.
Purpose of the Study:
- To characterize PXDN expression in IgA nephropathy (IgAN) kidney biopsies.
- To assess the association of PXDN with fibrosis and kidney function in IgAN.
Main Methods:
- Immunofluorescence staining of kidney biopsies from IgAN patients.
- Correlation analysis of PXDN expression with collagen deposition and estimated glomerular filtration rate (eGFR).
Main Results:
- PXDN expression was altered in a compartment-specific manner in IgAN kidneys.
- PXDN was reduced in proximal tubules and increased in the fibrotic interstitium.
- PXDN correlated with collagen III deposition and was higher in patients with impaired kidney function (eGFR < 60 mL/min/1.73 m²).
- Glomerular PXDN inversely correlated with eGFR.
Conclusions:
- PXDN expression is altered in IgAN, associated with interstitial fibrosis, collagen III deposition, and reduced kidney function.
- PXDN may play a role in fibrotic remodeling in IgAN.
- PXDN represents a potential therapeutic target for chronic kidney disease (CKD) progression.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
